ORANGEVALE, Calif.--(BUSINESS WIRE)--Biomagnetics Diagnostics Corp. (OTC: BMGP) CEO and President Clayton Hardman states, “BMGP welcomes the new administration’s support of Stem Cell Research, Biotechnology, and Genetic Engineering. Lifting restrictions on federal funding for research on new stem cell lines will have a global impact; with proper funding and political climate BMGP can complete an impressive agenda using our international resources and domestic assets. BMGP will participate in this leap forward for science and biotechnology, and look to increase shareholder value.”
